Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer

1. NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy

   Hamza Abu Owida, Ahmed Abed, Farag M. A. Altalbawy +7

   Шарҳ мақолаInflammasome and immune disordersNaunyn-Schmiedeberg s Archives of Pharmacology20251 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000073

2. LncRNAs in hypoxic microenvironment; insight in their impact in cancer biology

   Beena Briget Kuriakose, Ahmed Hjazi, Raed Obaid Saleh +7

   Шарҳ мақолаCancer-related molecular mechanisms researchFunctional & Integrative Genomics20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000115